Literature DB >> 36039232

Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report.

Haider Ghazanfar1, Misbahuddin Khaja2, Asim Haider3, Laura Yapor4, Sameer Kandhi5, Muhammad Sulh6.   

Abstract

Amyloidosis is a systemic disease that results from the extracellular deposition of an abnormal protein called amyloid. The kidney and the heart are the most common organ affected by amyloidosis while in some cases liver involvement can be seen. Our patient is a 60-year-old African American male who presented to the emergency department because of multiple episodes of syncope over the past day. Chest x-ray and ultrasound chest were suggestive of pleural effusion for which thoracentesis was done. His hospital course was complicated with renal and liver failure. Computed tomography (CT) abdomen and pelvis was done which showed mild hepatomegaly. Liver biopsy was done which showed congo red stain positive for amyloid. The patient's clinical condition continued to worsen and he was started on hemodialysis. During hospital course, the patient developed liver failure. His family members opted for palliative care and the patient passed away during the same admission. Physicians need to be aware of the detrimental course and poor prognosis associated with hepatic and renal amyloidosis. High clinical suspicion is needed to make an early diagnosis and initiate prompt treatment. Although clinical, laboratory and radiological findings can help in suggesting amyloidosis, a tissue biopsy is needed to confirm the diagnosis of amyloidosis.
Copyright © 2022, Ghazanfar et al.

Entities:  

Keywords:  hepatic amyloidosis; liver failure; morbidity and mortality; renal amyloidosis; renal failure

Year:  2022        PMID: 36039232      PMCID: PMC9403217          DOI: 10.7759/cureus.27274

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review.

Authors:  Martin Tam; David C Seldin; Benjamin M Forbes; Lawreen H Connors; Martha Skinner; Betul Oran; Karen Quillen; Vaishali Sanchorawala
Journal:  Amyloid       Date:  2009       Impact factor: 7.141

Review 2.  The Prevalence and Management of Systemic Amyloidosis in Western Countries.

Authors:  Hans L A Nienhuis; Johan Bijzet; Bouke P C Hazenberg
Journal:  Kidney Dis (Basel)       Date:  2016-02-25

3.  Primary hepatic amyloidosis: A case report and review of literature.

Authors:  Nikhil Sonthalia; Samit Jain; Sunil Pawar; Vinay Zanwar; Ravindra Surude; Praveen M Rathi
Journal:  World J Hepatol       Date:  2016-02-28

4.  Hepatic amyloidosis: clinical appraisal in 77 patients.

Authors:  M A Gertz; R A Kyle
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

5.  Amyloidosis: review of 236 cases.

Authors:  R A Kyle; E D Bayrd
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889

6.  Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.

Authors:  John L Berk; Joseph Keane; David C Seldin; Vaishali Sanchorawala; Jun Koyama; Laura M Dember; Rodney H Falk
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

Review 7.  Gastrointestinal manifestations of amyloidosis.

Authors:  Ellen C Ebert; Michael Nagar
Journal:  Am J Gastroenterol       Date:  2007-12-12       Impact factor: 10.864

8.  Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

Authors:  Miguel A Park; Paul S Mueller; Robert A Kyle; Dirk R Larson; Matthew F Plevak; Morie A Gertz
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

Review 9.   Primary hepatic amyloidosis: a mini literature review and five cases report.

Authors:  Ya-Dong Wang; Cai-Yan Zhao; Hong-Zhu Yin
Journal:  Ann Hepatol       Date:  2012 Sep-Oct       Impact factor: 2.400

10.  Epidemiology of AL amyloidosis: a real-world study using US claims data.

Authors:  Tiffany P Quock; Tingjian Yan; Eunice Chang; Spencer Guthrie; Michael S Broder
Journal:  Blood Adv       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.